Company Filing History:
Years Active: 1990-1992
Title: Innovations of Anne W Emerick
Introduction
Anne W Emerick is a notable inventor based in Oakland, California. She has made significant contributions to the field of biotechnology, particularly in the development of recombinant proteins and vaccines. With a total of two patents to her name, her work has implications for medical advancements and therapeutic applications.
Latest Patents
Emerick's latest patents include innovations related to recombinant ricin toxin fragments and recombinant diphtheria vaccines. The first patent claims ricin B muteins and ricin precursors that have been altered to decrease the binding of ricin B to galactosides. This includes DNA sequences encoding these muteins and expression vectors effective in expressing them. Additionally, the patent covers host cells transformed with these expression vectors and conjugates that comprise binding moieties bound to the ricin B mutein. The second patent focuses on recombinant diphtheria toxin A fragment muteins that are enzymatically inactive but immunologically crossreactive with diphtheria toxin. It also describes intermediates and methods for preparing such proteins using recombinant techniques.
Career Highlights
Emerick has worked at Cetus Corporation, where she has been involved in groundbreaking research and development. Her work has contributed to advancements in the field of immunology and therapeutic proteins.
Collaborations
Some of her notable coworkers include Lawrence I Greenfield and Walter J Laird, who have collaborated with her on various projects.
Conclusion
Anne W Emerick's contributions to biotechnology through her patents and research have paved the way for innovative medical solutions. Her work continues to influence the field and showcases the importance of innovation in science.